BriaCell Therapeutics Corp. (BCT)
Market Closed
30 Jul, 20:00
TSX 
CA$
5. 10
+0.27
+5.5901%
CA$
- Market Cap
- P/E Ratio
- Div Yield
3,344 Volume
- Eps
CA$ 4.83
Previous Close Want to track BCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BriaCell Therapeutics Corp. (BCT) Statistics
Valuation metrics
Market Cap -
Enterprise value -157.08K
Trailing P/E (ttm) -0.29
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 1.08
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.61K
Average volume (90 days) 9.65K
Price summary
52-Week low 3.68
52-Week high 20.4
Beta -
50-Day moving average 4.64
200-Day moving average 5.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 26 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.13%
Return on equity -1.48%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.15
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 7.07%
Book value per share (mrq) 3.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
